CureVac Historical Balance Sheet
CVAC Stock | USD 2.33 0.02 0.87% |
Trend analysis of CureVac NV balance sheet accounts such as Other Current Liab of 69.9 M, Total Current Liabilities of 179.9 M or Total Stockholder Equity of 422.9 M provides information on CureVac NV's total assets, liabilities, and equity, which is the actual value of CureVac NV to its prevalent stockholders. By breaking down trends over time using CureVac NV balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining CureVac NV latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CureVac NV is a good buy for the upcoming year.
CureVac NV Inventory |
|
CureVac |
About CureVac Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of CureVac NV at a specified time, usually calculated after every quarter, six months, or one year. CureVac NV Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CureVac NV and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CureVac currently owns. An asset can also be divided into two categories, current and non-current.
CureVac NV Balance Sheet Chart
CureVac NV Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how CureVac NV uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, CureVac NV's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Other Liabilities is expected to grow to about 198.2 M, whereas Total Assets are forecasted to decline to about 833 M. Add Fundamental
Total Assets
Total assets refers to the total amount of CureVac NV assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CureVac NV books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on CureVac NV balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CureVac NV are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from CureVac NV's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CureVac NV current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.At present, CureVac NV's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Other Liabilities is expected to grow to about 198.2 M, whereas Total Assets are forecasted to decline to about 833 M.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 176.3M | 46.2M | 53.2M | 69.9M | Total Assets | 1.2B | 860.5M | 989.5M | 833.0M |
CureVac NV balance sheet Correlations
Click cells to compare fundamentals
CureVac NV Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CureVac NV balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 130.6M | 1.5B | 1.2B | 860.5M | 989.5M | 833.0M | |
Other Current Liab | 13.3M | 68.8M | 176.3M | 46.2M | 53.2M | 69.9M | |
Total Current Liabilities | 28.1M | 247.6M | 357.7M | 156.2M | 179.7M | 179.9M | |
Total Stockholder Equity | (42.8M) | 711.3M | 688.5M | 533.3M | 613.2M | 422.9M | |
Net Tangible Assets | (48.2M) | 697.9M | 676.2M | 501.5M | 576.7M | 407.8M | |
Property Plant And Equipment Net | 66.8M | 104.8M | 200.4M | 241.7M | 278.0M | 145.0M | |
Current Deferred Revenue | 7.5M | 158.0M | 55.8M | 36.8M | 42.3M | 58.0M | |
Net Debt | 48.5M | (1.3B) | (782.6M) | (453.7M) | (408.3M) | (428.8M) | |
Retained Earnings | (515.9M) | (645.1M) | (1.1B) | (1.3B) | (1.2B) | (1.2B) | |
Accounts Payable | 5.3M | 17.6M | 122.3M | 68.2M | 78.5M | 48.9M | |
Cash | 30.7M | 1.3B | 811.5M | 495.8M | 570.2M | 590.0M | |
Non Current Assets Total | 73.4M | 121.5M | 218.2M | 276.4M | 317.9M | 163.3M | |
Non Currrent Assets Other | 967K | 1.1M | 1.2M | 1.7M | 1.9M | 1.1M | |
Other Assets | 6.3M | 7.5M | 5.6M | 3.0M | 2.7M | 4.6M | |
Cash And Short Term Investments | 32.1M | 1.3B | 816.1M | 500.3M | 575.3M | 601.6M | |
Net Receivables | 17.7M | 1.8M | 18.5M | 39.4M | 45.4M | 47.6M | |
Common Stock Shares Outstanding | 186.9M | 132.2M | 186.0M | 189.1M | 217.4M | 191.4M | |
Short Term Investments | 1.5M | 2.6M | 4.6M | 4.5M | 4.0M | 3.8M | |
Liabilities And Stockholders Equity | 130.6M | 1.5B | 1.2B | 860.5M | 989.5M | 833.0M | |
Non Current Liabilities Total | 145.3M | 552.4M | 112.0M | 171.0M | 196.6M | 230.2M | |
Capital Lease Obligations | 14.1M | 55.3M | 28.9M | 42.1M | 48.4M | 30.9M | |
Inventory | 6.2M | 14.5M | 56.2M | 24.0M | 27.6M | 22.8M | |
Other Current Assets | 1.2M | 48.3M | 49.2M | 5.3M | 6.1M | 5.8M | |
Other Stockholder Equity | 493.4M | 1.4B | (5.8M) | (1.5M) | (1.3M) | (1.3M) | |
Total Liab | 173.4M | 800.0M | 469.8M | 327.2M | 376.3M | 410.1M | |
Deferred Long Term Liab | 966K | 1.0M | 515K | 302K | 271.8K | 258.2K | |
Net Invested Capital | 22.2M | 711.3M | 688.5M | 533.3M | 613.2M | 437.2M | |
Property Plant And Equipment Gross | 61.7M | 104.8M | 247.4M | 258.7M | 297.5M | 156.9M | |
Total Current Assets | 57.2M | 1.4B | 940.0M | 584.0M | 671.6M | 669.7M | |
Accumulated Other Comprehensive Income | 472.4M | 1.3B | 1.7B | 1.8B | 2.1B | 1.3B | |
Non Current Liabilities Other | 529K | 284K | 264K | 19K | 17.1K | 16.2K | |
Net Working Capital | 29.1M | 1.1B | 582.3M | 427.8M | 492.0M | 489.8M | |
Short Term Debt | 2.0M | 3.2M | 3.5M | 5.0M | 5.7M | 3.1M | |
Intangible Assets | 5.7M | 14.1M | 13.2M | 19.3M | 22.2M | 12.9M |
Pair Trading with CureVac NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CureVac NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will appreciate offsetting losses from the drop in the long position's value.Moving against CureVac Stock
0.76 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
0.71 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
0.68 | ELYM | Eliem Therapeutics Upward Rally | PairCorr |
0.61 | HCWB | HCW Biologics | PairCorr |
0.56 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to CureVac NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CureVac NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CureVac NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CureVac NV to buy it.
The correlation of CureVac NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CureVac NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CureVac NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CureVac NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.Note that the CureVac NV information on this page should be used as a complementary analysis to other CureVac NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is CureVac NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.57) | Revenue Per Share 0.244 | Quarterly Revenue Growth 0.931 | Return On Assets (0.21) | Return On Equity (0.50) |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.